50 results
Page 2 of 3
8-K
EX-99.2
1o6 byzlb94zhnor
16 Aug 23
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
8:06am
8-K
EX-99.2
ur75n7
7 Aug 23
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.1
jrmw0sy9tlkgukel7h
12 Jun 23
Regulation FD Disclosure
8:07am
8-K
EX-1.1
hmgrt94u8f3q 3666
7 Jun 23
Day One Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
0e7zg7vjc373
7 Jun 23
Prospectus supplement for primary offering
4:57pm
424B5
jdh s374n28
6 Jun 23
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.1
rq1w42 p8
5 Jun 23
Regulation FD Disclosure
6:08am
8-K
EX-99.2
30pp2apz8 frx
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
PRE 14A
eht6wefkti92b
18 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.2
8ehilu
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
tk7ihxvr7rv
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.2
l701sjpge1rsay6fa4
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
nwpkt7 19jf
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
EX-1.1
453mzbt0sc057
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
424B5
ubtlvntkimtc5ponlph
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
q6w9aiy3j1j9qq
14 Jun 22
Prospectus supplement for primary offering
7:39am
8-K
EX-99.2
2pxwamc
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
S-3
EX-1.2
0kni3q981qpnnryetu
1 Jun 22
Shelf registration
4:06pm
S-3
tox 8ntid8a72r5sb1
1 Jun 22
Shelf registration
4:06pm